Sanofi and AstraZeneca's preventive RSV therapy appears safe: FDA staff https://ift.tt/Wm7b4L9

The companies are seeking the FDA's approval for use of the therapy in infants and children up to 24 months of age to protect them against lower respiratory tract disease that could cause pneumonia and bronchiolitis.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/cdt98uV
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.